InsidersTradesSigma
Follow the CLARIANE SE stock price and the full insider trade history of the company, a publicly traded company based in France. Shares are listed on the FR market, under the oversight of AMF. Operating in the Healthcare & Pharma sector, CLARIANE SE has logged 55 reports. Market capitalisation: €1.4bn. The latest transaction was disclosed on 28 August 2026 (Acquisition). Among the most active insiders: HLD Europe SCA. Every trade is free.
55
Insider Decl.
n/a
Thresholds
€49m
43 ops.
Buy Volume
€18m
2 ops.
Sell Volume
28Σ signal
Fundamental score
Ranked 13,422 of 29,064 companies
54.0
score / 100
Value67
Quality41
FCF yld59%
Earn yld0.1%
EV/EBITDA8.0x
ROE0.7%
Gross mgn92%
Net mgn0.0%
Debt/EBITDA6.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 28 August 2026
Declarations55 total
10,000 shares@ €4.000.0028% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1135176
Canonical exit: 22 Nov 2026 (T+90)
3,927 shares@ €4.000.0011% mcap0.0% of flowActionEuronext ParisISIN FR00103863342026DD1134655
Canonical exit: 17 Nov 2026 (T+90)
26,919 shares@ €3.99390.0074% mcap0.2% of flowActionEuronext ParisISIN FR00103863342026DD1133700
Canonical exit: 9 Nov 2026 (T+90)
2,033 shares@ €4.000.0006% mcap0.0% of flowActionEuronext ParisISIN FR00103863342026DD1132038
Canonical exit: 28 Oct 2026 (T+90)
16,894 shares@ €4.000.0046% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1122545
Canonical exit: 16 Sept 2026 (T+90)
54,085 shares0ActionEuronext ParisISIN FR00103863342026DD1121311
Canonical exit: 13 Sept 2026 (T+90)
21,451 shares@ €3.95690.0059% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1120442
Canonical exit: 6 Sept 2026 (T+90)
22,452 shares@ €3.99860.0063% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1119246
Canonical exit: 31 Aug 2026 (T+90)
18,400 shares@ €3.95970.0050% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1113076
Canonical exit: 29 Jul 2026 (T+90)
234,821 shares@ €3.98720.064% mcap1.5% of flowActionEuronext ParisISIN FR00103863342026DD1111340
Canonical exit: 23 Jul 2026 (T+90)
17,550 shares@ €3.91390.0049% mcap0.1% of flowActionEuronext ParisISIN FR00103863342026DD1098783
Canonical exit: 28 May 2026 (T+90)
18,221 shares@ €3.89130.1% of flowActionEuronext ParisISIN FR00103863342026DD1091554
Canonical exit: 23 Apr 2026 (T+90)
50,841 shares@ €3.78730.3% of flowActionEuronext ParisISIN FR00103863342026DD1090657
Canonical exit: 27 Apr 2026 (T+90)
50,841 shares@ €3.78730.3% of flowActionEuronext ParisISIN FR00103863342026DD1091076
Canonical exit: 19 Apr 2026 (T+90)
61,181 shares@ €3.78150.4% of flowActionEuronext ParisISIN FR00103863342026DD1089589
Canonical exit: 13 Apr 2026 (T+90)
24,890 shares@ €3.81110.1% of flowActionEuronext ParisISIN FR00103863342026DD1088726
Canonical exit: 7 Apr 2026 (T+90)
9,253 shares@ €3.92860.1% of flowActionEuronext ParisISIN FR00103863342026DD1087553
Canonical exit: 31 Mar 2026 (T+90)
7,430 shares@ €3.79230.0% of flowActionEuronext ParisISIN FR00103863342025DD1086629
Canonical exit: 24 Mar 2026 (T+90)
19,636 shares@ €3.77930.1% of flowActionEuronext ParisISIN FR00103863342025DD1086361
Canonical exit: 22 Mar 2026 (T+90)
12,893 shares@ €3.60330.1% of flowActionEuronext ParisISIN FR00103863342025DD1085730
Canonical exit: 16 Mar 2026 (T+90)
8,737 shares@ €3.81380.1% of flowActionEuronext ParisISIN FR00103863342025DD1074765
Canonical exit: 10 Mar 2026 (T+90)
22,654 shares@ €3.70490.1% of flowActionEuronext ParisISIN FR00103863342025DD1073837
Canonical exit: 4 Mar 2026 (T+90)
16,546 shares@ €3.69960.1% of flowActionEuronext ParisISIN FR00103863342025DD1072789
Canonical exit: 26 Feb 2026 (T+90)
19,601 shares@ €3.43540.1% of flowActionEuronext ParisISIN FR00103863342025DD1071810
Canonical exit: 22 Feb 2026 (T+90)
14,291 shares@ €3.32190.1% of flowActionEuronext ParisISIN FR00103863342025DD1070851
Canonical exit: 16 Feb 2026 (T+90)
25 of 55 declarations
关于 CLARIANE SE
Clariane SE 是欧洲领先的弱势人群护理、医疗保健和酒店服务提供商，核心业务聚焦于老龄化、依赖性以及医疗复杂护理需求。该公司历史名为 Korian，于 2003 年在法国成立，并于 2023 年更名为 Clariane，作为其广泛战略转型的一部分。此次转型伴随着采纳以目标为导向的公司地位，其使命是“在脆弱时期关怀每个人的尊严”，现已融入其公司治理和长期战略中。 Clariane 的商业模式围绕两个互补的部门构建：长期护理和专业护理。长期护理包括医疗辅助养老院、老年生活解决方案以及为老年居民提供的相关住宿服务。专业护理涵盖广泛的医疗保健服务，包括精神科护理、急性后期和康复服务、日间住院、门诊途径以及居家或社区护理。这种综合模式使集团能够应对从居住支持到更专业医疗治疗的整个患者旅程。 该集团在欧洲六个国家拥有重要的业务足迹：法国、德国、比利时、意大利、荷兰和西班牙。根据其公司披露，Clariane 运营着 1,215 家机构，雇佣约 70,000 名员工，服务 840,000 名居民和患者。这种规模使其在一个既高度本地化又高度受监管的行业中拥有强大的市场影响力，同时也使其面临各国报销系统、劳动力成本和医疗政策的差异。 从战略和财务角度来看，Clariane 自 2023 年以来一直在通过一项重大的资产负债表强化计划和资产剥离计划来重塑其投资组合。2025 年，该公司表示已提前六个月完成该计划，帮助其重新聚焦于两个核心业务。2024 财年，收入达到 5.282 billion 欧元，有机增长 6.6%，尽管环境充满挑战，但仍显示出强劲的潜在运营势头。 Clariane 还强调人力资本、培训和社会影响。它在法国推出了 Clariane University，以支持护理专业的技能发展，并于 2026 年连续第三年获得“欧洲最佳雇主”认证。这些举措，连同其使命驱动的地位和可持续发展承诺，支持了该公司作为与结构性人口顺风相符的欧洲主要护理平台的定位。
